These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12585026)

  • 1. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
    Wee A; Nilsson B
    Acta Cytol; 2003; 47(1):16-26. PubMed ID: 12585026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of diagnostic criteria for aspiration cytology of hepatocellular carcinoma.
    Takenaka A; Kaji I; Kasugai H; Sasaki Y; Ishiguro S; Wada A; Horai T; Otani T; Ishikawa H
    Acta Cytol; 1999; 43(4):610-6. PubMed ID: 10432883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic features and histologic correlations of microacinar and microtrabecular types of well-differentiated hepatocellular carcinoma in fine-needle aspiration biopsy.
    Yang GC; Yang GY; Tao LC
    Cancer; 2004 Feb; 102(1):27-33. PubMed ID: 14968415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytodiagnosis of well differentiated hepatocellular carcinoma: can indeterminate diagnoses be reduced?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 1999 Oct; 87(5):270-7. PubMed ID: 10536352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytodiagnosis of hepatocellular carcinoma in fine-needle aspirates of the liver: its differentiation from reactive hepatocytes and metastatic adenocarcinoma.
    Das DK
    Diagn Cytopathol; 1999 Dec; 21(6):370-7. PubMed ID: 10572267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
    Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.
    Kong CS; Appenzeller M; Ferrell LD
    Acta Cytol; 2000; 44(2):218-22. PubMed ID: 10740609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
    Gottschalk-Sabag S; Ron N; Glick T
    Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine needle aspiration biopsy of hepatocellular carcinoma. Some unusual features.
    Wee A; Nilsson B; Chan-Wilde C; Yap I
    Acta Cytol; 1991; 35(6):661-70. PubMed ID: 1659093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy.
    Solé M; Calvet X; Cuberes T; Maderuelo F; Bruix J; Bru C; Rey MJ; Serna N; Cardesa A
    Acta Cytol; 1993; 37(3):309-16. PubMed ID: 8388606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
    Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
    Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hepatocellular-cholangiocarcinoma. Diagnostic challenge in hepatic fine needle aspiration biopsy.
    Wee A; Nilsson B
    Acta Cytol; 1999; 43(2):131-8. PubMed ID: 10097699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine needle aspiration cytodiagnosis of liver tumors.
    Kuo FY; Chen WJ; Lu SN; Wang JH; Eng HL
    Acta Cytol; 2004; 48(2):142-8. PubMed ID: 15085744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytologic criteria to distinguish hepatocellular carcinoma from nonneoplastic liver.
    Cohen MB; Haber MM; Holly EA; Ahn DK; Bottles K; Stoloff AC
    Am J Clin Pathol; 1991 Feb; 95(2):125-30. PubMed ID: 1704175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An approach to the cytologic diagnostic criteria of hepatocellular carcinoma by fine needle aspiration biopsy].
    Pan Q; Cao J; Teng M
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):42-4. PubMed ID: 11776795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases.
    Longchampt E; Patriarche C; Fabre M
    Acta Cytol; 2000; 44(4):515-23. PubMed ID: 10934942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathologic grading of hepatocellular carcinoma on fine-needle aspiration.
    Kulesza P; Torbenson M; Sheth S; Erozan YS; Ali SZ
    Cancer; 2004 Aug; 102(4):247-58. PubMed ID: 15368317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F; Abdallah H; Meschter S
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma.
    Wee A; Nilsson B
    Acta Cytol; 1997; 41(4):1147-55. PubMed ID: 9250313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.